Stockscreener 앱 받기
3.03
3.50%
-0.11
전일 마감가:
$3.14
열려 있는:
$3.14
하루 거래량:
102.55K
Relative Volume:
0.30
시가총액:
$240.06M
수익:
$351.37M
순이익/손실:
$-174.01M
주가수익비율:
-1.4638
EPS:
-2.07
순현금흐름:
$-126.94M
1주 성능:
+4.12%
1개월 성능:
-3.50%
6개월 성능:
+11.81%
1년 성능:
-12.93%
1일 변동 폭
$3.005
$3.1458
1주일 범위
$2.895
$3.1684
52주 변동 폭
$2.455
$4.02
Atea Pharmaceuticals Inc Stock (AVIR) Company Profile
명칭
Atea Pharmaceuticals Inc
전화
857-204-8109
주소
225 FRANKLIN STREET, BOSTON
AVIR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVIR
Atea Pharmaceuticals Inc
|
3.025 | 249.18M | 351.37M | -174.01M | -126.94M | -2.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.18 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
471.48 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
552.36 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
808.25 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.09 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-13 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-08-10 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2022-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-18 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-10-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-25 | 개시 | Evercore ISI | Outperform |
| 2020-11-24 | 개시 | JP Morgan | Overweight |
| 2020-11-24 | 개시 | Morgan Stanley | Overweight |
| 2020-11-24 | 개시 | William Blair | Outperform |
모두보기
Atea Pharmaceuticals Inc 주식(AVIR)의 최신 뉴스
What MACD signals say about Atea Pharmaceuticals Inc.2025 Price Action Summary & Detailed Earnings Play Alerts - newser.com
Atea Pharmaceuticals Inc. stock trend outlook and recovery pathRisk Management & Technical Confirmation Alerts - newser.com
How hedge fund analytics apply to Atea Pharmaceuticals Inc. stock - newser.com
Will Atea Pharmaceuticals Inc. stock go up soonJuly 2025 Selloffs & Free AI Powered Buy and Sell Recommendations - newser.com
How to recover losses in Atea Pharmaceuticals Inc. stockWeekly Gains Report & Weekly Watchlist for Hot Stocks - newser.com
Analyzing recovery setups for Atea Pharmaceuticals Inc. investorsJuly 2025 Short Interest & AI Powered Market Entry Ideas - newser.com
What’s the recovery path for long term holders of Atea Pharmaceuticals Inc.Weekly Stock Recap & Real-Time Market Sentiment Alerts - newser.com
Weiss Ratings Reiterates "Sell (D-)" Rating for Atea Pharmaceuticals (NASDAQ:AVIR) - MarketBeat
What analysts say about Atea Pharmaceuticals Inc stockBearish Engulfing Patterns & Market-Leading Growth Rates - earlytimes.in
Atea Pharmaceuticals to Present New Data Supporting Combination of Bemnifosbuvir and Ruzasvir as Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Liver Meeting® 2025 - GlobeNewswire
Why Atea Pharmaceuticals Inc. stock is a must watch in 2025July 2025 Snapshot & Daily Profit Focused Screening - newser.com
Market reaction to Atea Pharmaceuticals Inc.’s recent news2025 Historical Comparison & Precise Swing Trade Entry Alerts - newser.com
Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing - Bain Capital
Relative strength of Atea Pharmaceuticals Inc. in sector analysisEarnings Overview Summary & Free High Accuracy Swing Entry Alerts - newser.com
Does Atea Pharmaceuticals Inc. show high probability of rebound2025 Top Gainers & Smart Allocation Stock Tips - newser.com
Using portfolio simulators with Atea Pharmaceuticals Inc. includedLayoff News & Accurate Buy Signal Notifications - newser.com
Historical volatility pattern of Atea Pharmaceuticals Inc. visualizedPortfolio Update Report & Free Expert Verified Stock Movement Alerts - newser.com
What machine learning models say about Atea Pharmaceuticals Inc.Weekly Gains Summary & Community Verified Swing Trade Signals - newser.com
How to manage a losing position in Atea Pharmaceuticals Inc.July 2025 Trends & Weekly Return Optimization Alerts - newser.com
Voya Investment Management LLC Reduces Stock Position in Atea Pharmaceuticals, Inc. $AVIR - Defense World
What drives Atea Pharmaceuticals Inc stock priceInstitutional Buying Trends & Machine Learning Stock Picks, Daily - earlytimes.in
Atea Pharmaceuticals Inc (AVIR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Atea Pharmaceuticals Inc 주식 (AVIR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BERGER FRANKLIN M | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
506,497 |
| Duncan Barbara Gayle | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Polsky Bruce | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
95,206 |
| Adams Jerome M. | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Lucidi Bruno | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
112,750 |
| BERGER FRANKLIN M | Director |
Dec 10 '24 |
Sale |
2.85 |
359,606 |
1,023,475 |
451,897 |
0.86%
자본화:
|
볼륨(24시간):